1. Home
  2. BBW vs ZURA Comparison

BBW vs ZURA Comparison

Compare BBW & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Build-A-Bear Workshop Inc.

BBW

Build-A-Bear Workshop Inc.

HOLD

Current Price

$25.16

Market Cap

473.7M

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$4.35

Market Cap

455.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBW
ZURA
Founded
1997
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
473.7M
455.4M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
BBW
ZURA
Price
$25.16
$4.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
7
Target Price
★ $45.00
$19.00
AVG Volume (30 Days)
286.8K
★ 4.5M
Earning Date
12-03-2026
10-27-2026
Dividend Yield
★ 3.75%
N/A
EPS Growth
★ 5.00
N/A
EPS
★ 2.16
N/A
Revenue
★ $357,866,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.33
N/A
P/E Ratio
$11.39
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$23.19
$3.25
52 Week High
$72.19
$7.25

Technical Indicators

Market Signals
Indicator
BBW
ZURA
Relative Strength Index (RSI) 48.37 51.47
Support Level $24.29 $3.99
Resistance Level $26.40 $6.05
Average True Range (ATR) 1.01 0.49
MACD 0.19 0.06
Stochastic Oscillator 65.68 66.23

Price Performance

Historical Comparison
BBW
ZURA

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments: Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, U.K., Ireland, and two e-commerce sites, the international franchising segment includes royalties and product and fixture sales from other international operations under franchise agreements, and the commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Share on Social Networks: